Carfilzomib and dexamethasone vs bortezomib and dexamethasone in patients with relapsed multiple myeloma: results of the phase 3 study ENDEAVOR (NCT01568866) according to age subgroup - Ludwig, Heinz; Goldschmidt, Hartmut (Leukemia and lymphoma, 2017)